METABOLIC & INCRETIN RESEARCH
SEMAGLUTIDE
GLP 1 receptor agonist with established human clinical evidence in metabolic and weight management research.
TIRZEPATIDE
Dual GIP and GLP 1 receptor agonist studied extensively in human metabolic, glycemic, and weight management research.
RETATRUTIDE
Investigational triple receptor agonist targeting GIP, GLP 1, and glucagon signaling pathways.
AOD9604
Modified fragment of human growth hormone investigated primarily in metabolic and fat metabolism research.